Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 69

1.

Effectiveness of pre-entry active tuberculosis and post-entry latent tuberculosis screening in new entrants to the UK: a retrospective, population-based cohort study.

Berrocal-Almanza LC, Harris R, Lalor MK, Muzyamba MC, Were J, O'Connell AM, Mirza A, Kon OM, Lalvani A, Zenner D.

Lancet Infect Dis. 2019 Nov;19(11):1191-1201. doi: 10.1016/S1473-3099(19)30260-9. Epub 2019 Aug 27.

3.

Predicting STI Diagnoses Amongst MSM and Young People Attending Sexual Health Clinics in England: Triage Algorithm Development and Validation Using Routine Clinical Data.

King C, Hughes G, Furegato M, Mohammed H, Were J, Copas A, Gilson R, Shahmanesh M, Mercer CH.

EClinicalMedicine. 2018 Nov 28;4-5:43-51. doi: 10.1016/j.eclinm.2018.11.002. eCollection 2018 Oct-Nov.

4.

Infectious disease testing of UK-bound refugees: a population-based, cross-sectional study.

Crawshaw AF, Pareek M, Were J, Schillinger S, Gorbacheva O, Wickramage KP, Mandal S, Delpech V, Gill N, Kirkbride H, Zenner D.

BMC Med. 2018 Aug 28;16(1):143. doi: 10.1186/s12916-018-1125-4.

5.

COHORT PROFILE: The Complications of Long-Term Antiretroviral Therapy study in Uganda (CoLTART), a prospective clinical cohort.

Mayanja BN, Kasamba I, Levin J, Namakoola I, Kazooba P, Were J, Kaleebu P, Munderi P; CoLTART study team.

AIDS Res Ther. 2017 May 4;14:26. doi: 10.1186/s12981-017-0154-y. eCollection 2017.

6.

Prevalence and characteristics of gastrointestinal infections in men who have sex with men diagnosed with rectal chlamydia infection in the UK: an 'unlinked anonymous' cross-sectional study.

Hughes G, Silalang P, Were J, Patel H, Childs T, Alexander S, Duffell S, Saxon C, Ison C, Mitchell H, Field N, Jenkins C.

Sex Transm Infect. 2018 Nov;94(7):518-521. doi: 10.1136/sextrans-2016-053057. Epub 2017 Mar 30.

PMID:
28360379
7.

Mobile phone-delivered reminders and incentives to improve childhood immunisation coverage and timeliness in Kenya (M-SIMU): a cluster randomised controlled trial.

Gibson DG, Ochieng B, Kagucia EW, Were J, Hayford K, Moulton LH, Levine OS, Odhiambo F, O'Brien KL, Feikin DR.

Lancet Glob Health. 2017 Apr;5(4):e428-e438. doi: 10.1016/S2214-109X(17)30072-4.

8.

Access of non-specialist sexual health services by men who have sex with men: do they differ from those attending specialist services?

Mebrahtu H, Furegato M, Sile B, Were J, Mohammed H, Hughes G.

Sex Transm Infect. 2018 Feb;94(1):72-74. doi: 10.1136/sextrans-2016-052755. Epub 2016 Nov 25.

PMID:
27888206
9.

The effect of Tenofovir on renal function among Ugandan adults on long-term antiretroviral therapy: a cross-sectional enrolment analysis.

Salome T, Kasamba I, Mayanja BN, Kazooba P, Were J, Kaleebu P, Munderi P; CoLTART study team.

AIDS Res Ther. 2016 Aug 30;13(1):28. doi: 10.1186/s12981-016-0113-z. eCollection 2016.

10.

Sexualised drug use in people attending sexual health clinics in England.

Mohammed H, Were J, King C, Furegato M, Nardone A, Hughes G; GUMCADv3 Steering Group.

Sex Transm Infect. 2016 Sep;92(6):454. doi: 10.1136/sextrans-2016-052740. No abstract available.

PMID:
27543514
11.

Decreased renal function and associated factors in cities, towns and rural areas of Tanzania: a community-based population survey.

Peck R, Baisley K, Kavishe B, Were J, Mghamba J, Smeeth L, Grosskurth H, Kapiga S.

Trop Med Int Health. 2016 Mar;21(3):393-404. doi: 10.1111/tmi.12651. Epub 2015 Dec 28.

12.

Prevalence of bloodstream pathogens is higher in neonatal encephalopathy cases vs. controls using a novel panel of real-time PCR assays.

Tann CJ, Nkurunziza P, Nakakeeto M, Oweka J, Kurinczuk JJ, Were J, Nyombi N, Hughes P, Willey BA, Elliott AM, Robertson NJ, Klein N, Harris KA.

PLoS One. 2014 May 16;9(5):e97259. doi: 10.1371/journal.pone.0097259. eCollection 2014.

13.

Longitudinal evaluation of severely anemic children in Kenya: the effect of transfusion on mortality and hematologic recovery.

Lackritz EM, Hightower AW, Zucker JR, Ruebush TK 2nd, Onudi CO, Steketee RW, Were JB, Patrick E, Campbell CC.

AIDS. 1997 Oct;11(12):1487-94.

PMID:
9342071
14.

Childhood mortality during and after hospitalization in western Kenya: effect of malaria treatment regimens.

Zucker JR, Lackritz EM, Ruebush TK 2nd, Hightower AW, Adungosi JE, Were JB, Metchock B, Patrick E, Campbell CC.

Am J Trop Med Hyg. 1996 Dec;55(6):655-60. Erratum in: Am J Trop Med Hyg 1997 Mar;56(3):358.

PMID:
9025694
15.

Field detection of sulfonamides in urine: the development of a new and sensitive test.

Mount DL, Green MD, Zucker JR, Were JB, Todd GD.

Am J Trop Med Hyg. 1996 Sep;55(3):250-3.

PMID:
8842109
16.

Plasmodium falciparum circumsporozoite vaccine immunogenicity and efficacy trial with natural challenge quantitation in an area of endemic human malaria of Kenya.

Sherwood JA, Copeland RS, Taylor KA, Abok K, Oloo AJ, Were JB, Strickland GT, Gordon DM, Ballou WR, Bales JD Jr, Wirtz RA, Wittes J, Gross M, Que JU, Cryz SJ, Oster CN, Roberts CR, Sadoff JC.

Vaccine. 1996 Jun;14(8):817-27.

PMID:
8817830
17.

Acute phase protein concentrations predict parasite clearance rate during therapy for visceral leishmaniasis.

Wasunna KM, Raynes JG, Were JB, Muigai R, Sherwood J, Gachihi G, Carpenter L, McAdam KP.

Trans R Soc Trop Med Hyg. 1995 Nov-Dec;89(6):678-81.

PMID:
8594695
18.

Problems in the treatment of kala-azar: case report.

Nyakundi PM, Rashid JR, Wasunna KM, Were JB, Muigai R, Kirigi G, Mbugua J.

East Afr Med J. 1995 Jun;72(6):406-8.

PMID:
7498017
19.

Phase 2 efficacy trial of an oral 8-aminoquinoline (WR6026) for treatment of visceral leishmaniasis.

Sherwood JA, Gachihi GS, Muigai RK, Skillman DR, Mugo M, Rashid JR, Wasunna KM, Were JB, Kasili SK, Mbugua JM, et al.

Clin Infect Dis. 1994 Dec;19(6):1034-9.

PMID:
7888530
20.

Relationship between direct agglutination test and splenic aspirate smear parasite load in visceral leishmaniasis at Baringo District, Kenya.

Nyakundi PM, Gachihi GS, Muigai RK, Were JB, Wasunna KM, Rashid RJ, Ogola JJ, Kirigi G, Mbugua J.

East Afr Med J. 1994 Sep;71(9):598-600.

PMID:
7875095
21.

Anaemia, blood transfusion practices, HIV and mortality among women of reproductive age in western Kenya.

Zucker JR, Lackritz EM, Ruebush TK, Hightower AW, Adungosi JE, Were JB, Campbell CC.

Trans R Soc Trop Med Hyg. 1994 Mar-Apr;88(2):173-6.

PMID:
8036663
22.

A comparison of amodiaquine and chloroquine in the treatment therapy of falciparum malaria in Kenya.

Nevill CG, Verhoeff FH, Munafu CG, ten Hove WR, van der Kaay HJ, Were JB.

East Afr Med J. 1994 Mar;71(3):167-70.

PMID:
7956864
23.

The effect of human immunodeficiency virus type-1 on the infectiousness of tuberculosis.

Nunn P, Mungai M, Nyamwaya J, Gicheha C, Brindle RJ, Dunn DT, Githui W, Were JO, McAdam KP.

Tuber Lung Dis. 1994 Feb;75(1):25-32.

PMID:
8161761
24.

Human cutaneous leishmaniasis caused by Leishmania donovani s.l. in Kenya.

Mebrahtu YB, Van Eys G, Guizani I, Lawyer PG, Pamba H, Koech D, Roberts C, Perkins PV, Were JB, Hendricks LD.

Trans R Soc Trop Med Hyg. 1993 Sep-Oct;87(5):598-601.

PMID:
8266420
25.

Blood transfusion practices and blood-banking services in a Kenyan hospital.

Lackritz EM, Ruebush TK 2nd, Zucker JR, Adungosi JE, Were JB, Campbell CC.

AIDS. 1993 Jul;7(7):995-9.

PMID:
8357559
26.

Factors affecting exflagellation of in vitro-cultivated Plasmodium falciparum gametocytes.

Ogwan'g RA, Mwangi JK, Githure J, Were JB, Roberts CR, Martin SK.

Am J Trop Med Hyg. 1993 Jul;49(1):25-9.

PMID:
8352388
27.

Field application of an ELISA using redefined Leishmania antigens for the detection of visceral leishmaniasis.

Okong'o-Odera EA, Wamachi A, Kagai JM, Kurtzhals JA, Githure JI, Hey AS, Were JB, Koech DK, Mitema ES, Kharazmi A.

Trans R Soc Trop Med Hyg. 1993 Jul-Aug;87(4):423-4.

PMID:
8249071
28.

Effects of probenecid on the pharmacokinetics of allopurinol riboside.

Were JB, Shapiro TA.

Antimicrob Agents Chemother. 1993 May;37(5):1193-6.

29.

Immunochemotherapy for visceral leishmaniasis: a controlled pilot trial of antimony versus antimony plus interferon-gamma.

Squires KE, Rosenkaimer F, Sherwood JA, Forni AL, Were JB, Murray HW.

Am J Trop Med Hyg. 1993 May;48(5):666-9.

PMID:
8390795
30.

Beyond chloroquine: implications of drug resistance for evaluating malaria therapy efficacy and treatment policy in Africa.

Bloland PB, Lackritz EM, Kazembe PN, Were JB, Steketee R, Campbell CC.

J Infect Dis. 1993 Apr;167(4):932-7.

PMID:
8450258
31.

A new focus of kala-azar due to Leishmania donovani sensu lato in Kenya.

Johnson RN, Ngumbi PM, Gachihi GS, Mwanyumba JP, Mbugua J, Mosonik N, Were JB, Roberts CR.

Trans R Soc Trop Med Hyg. 1993 Mar-Apr;87(2):142-4.

PMID:
8337711
32.

Biochemical characterization and zymodeme classification of Leishmania isolates from patients, vectors, and reservoir hosts in Kenya.

Mebrahtu YB, Lawyer PG, Pamba H, Koech D, Perkins PV, Roberts CR, Were JB, Hendricks LD.

Am J Trop Med Hyg. 1992 Dec;47(6):852-92.

PMID:
1471744
33.

Effect of blood transfusion on survival among children in a Kenyan hospital.

Lackritz EM, Campbell CC, Ruebush TK 2nd, Hightower AW, Wakube W, Steketee RW, Were JB.

Lancet. 1992 Aug 29;340(8818):524-8.

PMID:
1354285
34.

Prophylactic phenobarbitone in young children with severe falciparum malaria: pharmacokinetics and clinical effects.

Winstanley PA, Newton CR, Pasvol G, Kirkham FJ, Mberu E, Peshu N, Ward SA, Were JB, Warrell DA, Marsh K.

Br J Clin Pharmacol. 1992 Feb;33(2):149-54.

35.

Cross-sectional survey of HIV infection among patients with tuberculosis in Nairobi, Kenya.

Nunn P, Gicheha C, Hayes R, Gathua S, Brindle R, Kibuga D, Mutie T, Kamunyi R, Omwega M, Were J, et al.

Tuber Lung Dis. 1992 Feb;73(1):45-51.

PMID:
1381970
36.

The presentation and outcome of HIV-related disease in Nairobi.

Gilks CF, Otieno LS, Brindle RJ, Newnham RS, Lule GN, Were JB, Simani PM, Bhatt SM, Okelo GB, Waiyaki PG, et al.

Q J Med. 1992 Jan;82(297):25-32.

PMID:
1438666
37.

Quinine treatment of severe falciparum malaria in African children: a randomized comparison of three regimens.

Pasvol G, Newton CR, Winstanley PA, Watkins WM, Peshu NM, Were JB, Marsh K, Warrell DA.

Am J Trop Med Hyg. 1991 Dec;45(6):702-13.

PMID:
1763797
38.

Post kala-azar dermal leishmaniasis: the Kenyan experience.

Muigai R, Gachihi GS, Oster CN, Were JB, Nyakundi PM, Chunge CN, Kirigi G, Rashid JR.

East Afr Med J. 1991 Oct;68(10):801-6.

PMID:
1667521
39.

Comparative humoral responses to HIV-1 p24gag and gp120env in subjects from East Africa and the UK.

Kaleebu P, Cheingsong-Popov R, Callow D, Katabira E, Mubiru F, Biryahwaho B, Sempala S, Gilks C, Brindle R, Were JB, et al.

AIDS. 1991 Aug;5(8):1015-9.

PMID:
1777160
40.

Sensitivity of falciparum malaria to chloroquine and amodiaquine in four districts of western Kenya (1985-1987).

Oloo AJ, Adoyo A, Kariuki D, Boriga DA, Magiri C, Were JB, Koech DK.

East Afr Med J. 1991 Aug;68(8):606-10.

PMID:
1765012
41.

Bacterial infection of hydatid cyst following albendazole treatment.

Wasunna KM, Were JB, Romig T, Rees PH, Sherwood JA.

Ann Trop Med Parasitol. 1991 Jun;85(3):369-70. No abstract available.

PMID:
1746988
42.

Pharmacokinetics and metabolism of allopurinol riboside.

Shapiro TA, Were JB, Danso K, Nelson DJ, Desjardins RE, Pamplin CL 3rd.

Clin Pharmacol Ther. 1991 May;49(5):506-14.

PMID:
2029827
43.

Safety and immunogenicity of a Plasmodium falciparum sporozoite vaccine: boosting of antibody response in a population with prior natural exposure to malaria.

Sherwood JA, Oster CN, Adoyo-Adoyo M, Beier JC, Gachihi GS, Nyakundi PM, Ballou WR, Brandling-Bennett AD, Schwartz IK, Were JB, et al.

Trans R Soc Trop Med Hyg. 1991 May-Jun;85(3):336-40.

PMID:
1949134
44.

Cutaneous hypersensitivity reactions due to thiacetazone in HIV-1 seropositive patients treated for tuberculosis.

Nunn P, Kibuga D, Gathua S, Brindle R, Imalingat A, Wasunna K, Lucas S, Gilks C, Omwega M, Were J, et al.

Lancet. 1991 Mar 16;337(8742):627-30.

PMID:
1705647
45.

Activation of human T lymphocytes by Leishmania lipophosphoglycan.

Kemp M, Theander TG, Handman E, Hey AS, Kurtzhals JA, Hviid L, Sørensen AL, Were JO, Koech DK, Kharazmi A.

Scand J Immunol. 1991 Feb;33(2):219-24.

PMID:
1902000
46.

AIDS in Africa: the first decade and challenges for the 1990s.

Piot P, Kapita BM, Were JB, Laga M, Colebunders RL.

AIDS. 1991;5 Suppl 1:S1-5. Review.

PMID:
1669905
47.

Quantitative in vitro drug potency and drug susceptibility evaluation of Leishmania ssp. from patients unresponsive to pentavalent antimony therapy.

Jackson JE, Tally JD, Ellis WY, Mebrahtu YB, Lawyer PG, Were JB, Reed SG, Panisko DM, Limmer BL.

Am J Trop Med Hyg. 1990 Nov;43(5):464-80.

PMID:
2173431
48.

Comparison of chloroquine, pyrimethamine and sulfadoxine, and chlorproguanil and dapsone as treatment for falciparum malaria in pregnant and non-pregnant women, Kakamega District, Kenya.

Keuter M, van Eijk A, Hoogstrate M, Raasveld M, van de Ree M, Ngwawe WA, Watkins WM, Were JB, Brandling-Bennett AD.

BMJ. 1990 Sep 8;301(6750):466-70.

49.

An effective traditional medicine for bronchial asthma: clinical demonstration and preliminary toxicological evaluation.

Aluoch JA, Kofi-Tsekpo WM, Were JB, Oyuga HW, Wakori E, Nganga LW, Obuya CO.

Anc Sci Life. 1990 Jul;10(1):45-51.

50.

Permethrin-impregnated curtains and bed-nets prevent malaria in western Kenya.

Sexton JD, Ruebush TK 2nd, Brandling-Bennett AD, Breman JG, Roberts JM, Odera JS, Were JB.

Am J Trop Med Hyg. 1990 Jul;43(1):11-8.

PMID:
2200287

Supplemental Content

Support Center